Journal
MOLECULAR AND CELLULAR NEUROSCIENCE
Volume 55, Issue -, Pages 1-12Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.mcn.2012.08.013
Keywords
Mitochondrial encephalopathies; Translation; Ribosome; Assembly factors
Categories
Funding
- Medical Research Council, UK
- European Union
- National Institutes of Health, Bethesda, USA
- Medical Research Council [1456890, MC_PC_13029/1, MC_U105697134] Funding Source: researchfish
- MRC [MC_U105697134, MC_PC_13029/1] Funding Source: UKRI
Ask authors/readers for more resources
Mitochondrial diseases comprise a heterogeneous group of disorders characterized by compromised energy production. Since the early days of mitochondrial medical genetics, it has been known that these can be caused by defects in mitochondrial protein synthesis. However, only in recent years have we begun to develop a broader picture of the array of proteins required for mitochondrial translation. With this new knowledge has come the realization that there are many more neurological and other, diseases attributable to impaired mitochondrial translation than previously thought. Perturbation of any part of this intricate machinery, from the primary sequence of transfer or ribosomal RNAs, to the proteolytic processing of ribosomal proteins, can cause mitochondrial dysfunction and disease. In this review we discuss the current understanding of the mechanisms and factors involved in mammalian mitochondrial translation, and the diverse pathologies resulting when it malfunctions. This article is part of a Special Issue entitled 'Mitochondrial function and dysfunction in neurodegeneration'. (C) 2012 Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available